Cargando…
Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways
Immunomodulatory drugs (IMiDs) lenalidomide and pomalidomide show remarkable anti-tumor activity in multiple myeloma (MM) via directly inhibiting MM cell growth in the bone marrow (BM) microenvironment and promoting immune effector cell function. They are known to bind to the ubiquitin 3 ligase CRBN...
Autores principales: | Hideshima, Teru, Ogiya, Daisuke, Liu, Jiye, Harada, Takeshi, Kurata, Keiji, Bae, Jooeun, Massefski, Walter, Anderson, Kenneth C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529681/ https://www.ncbi.nlm.nih.gov/pubmed/32238854 http://dx.doi.org/10.1038/s41375-020-0809-x |
Ejemplares similares
-
T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival
por: de Mel, Sanjay, et al.
Publicado: (2022) -
Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT
por: Lo, Wan-Lin, et al.
Publicado: (2018) -
ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment
por: Liu, Jiye, et al.
Publicado: (2021) -
Reconstitution of T cell receptor signaling in ZAP-70-deficient cells by retroviral transduction of the ZAP-70 gene
Publicado: (1996) -
In silico analysis of enantioselective binding of immunomodulatory imide drugs to cereblon
por: Murai, Takahiro, et al.
Publicado: (2016)